Global Digoxin Market Size To Worth USD 78.31 Million by 2033 | CAGR of 3.01%
Category: HealthcareGlobal Digoxin Market Size To Worth USD 78.31 Million by 2033
According to a Research Report Published by Spherical Insights & Consulting, The Global Digoxin Market Size is Expected to Grow from USD 58.19 Million in 2023 to USD 78.31 Million by 2033, at a CAGR of 3.01% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 280 pages with 100 Market data tables and figures & charts from the report on the "Global Digoxin Market Size, Share, and COVID-19 Impact Analysis, By Type (Purity Below 98% and Purity Above 98%), By Application (Injection Product and Tablet Product), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/digoxin-market
The global digoxin market focuses on the development, production, and commercialization of digoxin, a cardiac glycoside agent used in managing cardiovascular diseases like atrial fibrillation and heart failure. Digoxin, derived from Digitalis lanata, is licensed by the US FDA to treat mild-to-moderate heart disorders. Its positive inotropic effect increases myocardial contraction and AV node inhibition, regulating ventricular response rates and improving cardiac output. The market growth is driven by government initiatives, such as research funding grants, and the rise in awareness and treatment concern for non-communicable diseases (NCDs). The National Programme for Prevention and Control of Diabetes, Cardiovascular Diseases, Stroke, and Cancer (NPCDCS) in India aims to address NCDs, resulting in increased demand for cardiovascular medications like digoxin. The increasing prevalence of heart failure also accelerates the need for digoxin, with the market growth projected to exceed 78.31 million by 2033. However, stringent regulatory guidelines may impede the growth of the market.
The purity above 98% segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the type, the global digoxin market is categorized as purity below 98% and purity above 98%. Among these, the purity above 98% segment held the largest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. The increased safety profile, reduced risk of side effects, increased bioavailability, consistent medication content, and enhanced therapeutic efficacy are all factors contributing to the segmental growth.
The tablet product segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global digoxin market is categorized as an injection product and tablet product. Among these, the tablet product segment accounted for the highest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. Easy administration, patient compliance, high physio-chemical stability, quick dissolution rate, cost-effectiveness, precise dosage, extended shelf life, better cardiac output, and higher bioavailability are all factors contributing to the segment's growth.
North America is expected to hold the greatest share of the global digoxin market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global Digoxin market over the forecast period. The market growth in this region is driven by the demand for generic drugs, particularly orally disintegrating tablets, for treating neurological disorders, driven by technological advancements, R&D expenditure, and government support.
Asia Pacific is predicted to grow at the fastest throughout the estimated period. Digoxin, a vital therapy, is in high demand due to heart failure and atrial fibrillation, the rising older population in emerging economies, growing access to healthcare, supportive laws, research, and early detection and treatment programs.
Major key players in the global digoxin market are Alchem, Alkaloids Corporation, C2 Pharma, Vital Labs, Amgen Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Zydus Cadila, Mylan N.V., Pfizer Inc., AstraZeneca plc, Sun Pharmaceutical Laboratories Ltd., and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In June 2023, C2 PHARMA, a company that manufactures and supplies active pharmaceutical ingredients (APIs), approved a C-Drug Master Filing for Digoxin, an API manufactured by Polish partner Nobilus Ent. The approval covers both Digoxin and Digoxin micronized and supports different dosage forms for oral and injectable drug product formulations. Digoxin, derived from the Digitalis lanata plant, is commonly used in clinical practice for treating mild to moderate heart failure as a cardiac glycoside.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global digoxin market based on the below-mentioned segments:
Global Digoxin Market, By Type
- Purity Below 98%
- Purity Above 98%
Global Digoxin Market, By Application
- Injection Product
- Tablet Product
Global Digoxin Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?